Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation
NCT ID: NCT02695979
Last Updated: 2018-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2014-08-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tissue Microdialysis Monitoring of Liver Grafts
NCT06890234
Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
NCT06838702
Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation
NCT06169592
Postoperative Complications After Liver Transplantation
NCT02761109
Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients
NCT00698399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients undergoing OLT
Patients aged 18-70 with end-stage liver disease undergoing orthotopic liver transplantation (OLT).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Joanna Stefaniak
Dr.med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Faybik, Prof
Role: STUDY_CHAIR
Medical University Vienna, Department of Anesthesia, General Intensive Care and Pain Management
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1458/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.